[Treatment of cutaneous porphyrias].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D003676:Deferoxamine / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D006801:Humans; D011164:Porphyrias / Q000150:complications*; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology*; D014815:Vitamins / Q000627:therapeutic use
D045930:Anabolic Agents; D014815:Vitamins; D000324:Adrenocorticotropic Hormone; D004492:Edetic Acid; D003676:Deferoxamine
Tratmentul porfiriilor cutanate.